News

The Carpentier-Edwards Physio II ring is a novel mitral valve repair solution. It is the only annuloplasty ring offering ‘shape optimization’, which matches the geometry of the ring

Sirion Therapeutics is seeking approval for ganciclovir as a treatment for herpetic keratitis, an ocular disease caused by the herpes simplex virus. The FDA has issued an action

The company has reduced its headcount by 17 since June 2008, from 42 to 25, including the closure of its therapeutics business in Boston. This is the end

Investors will also receive warrants to purchase 14.22 million shares of Avi BioPharma common stock. The closing of the offering is expected to take place on January 30,

Mylan has been awarded 180 days of marketing exclusivity for the 500mg strength, which it will begin to ship February 2, 2009. Mylan was the first company to

Mr Pauli has been CFO of OctoPlus since January 1, 2003. The executive board will aim to fill the vacancy of CFO as soon as possible. Simon Sturge,

The committee consists of John Kapoor, chairman of the board of directors and directors Randall Wall and Jerry Ellis. Dr Kapoor said: “Our current management team will execute

Under the agreement, Fujirebio Diagnostics will develop and manufacture for Abbott the HE4 biomarker, a simple blood test that may help in the risk stratification of women at

Prior to joining Synergetics, Mr Hable served as president and CEO of Afferent, a venture capital backed medical device company focused on neuro stimulation therapies. Previously, Mr Hable